Investment
Samsung Invests in Generate: Biomedicines to Advance AI-Driven Protein Therapeutics Discovery
Samsung Biologics
PR-12-24-NI-141Dec 18, 2024
Acquisition
Impact Biomedicines Acquired By Celgene
Emilie Branch
Pharma's Almanac
PAO-M01-18-NI-027Jan 16, 2018